Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Introduction
Synaptic dysfunction and degeneration is one of the earliest events in Alzheimer's disease (AD) and the best correlate of cognitive decline. Thus, identification and validation of biomarkers reflecting synaptic degeneration to be used as prognostic biomarkers are greatly needed.
Method
Solid‐phase extraction and parallel react...
Alternative Titles
Full title
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_94a7413bd307460086432a81c8853748
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_94a7413bd307460086432a81c8853748
Other Identifiers
ISSN
2352-8729
E-ISSN
2352-8729
DOI
10.1002/dad2.12179
